rs148291843

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001128225.3(SLC39A13):ā€‹c.439C>Gā€‹(p.Gln147Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00265 in 1,614,098 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0021 ( 3 hom., cov: 33)
Exomes š‘“: 0.0027 ( 8 hom. )

Consequence

SLC39A13
NM_001128225.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 3.85
Variant links:
Genes affected
SLC39A13 (HGNC:20859): (solute carrier family 39 member 13) This gene encodes a member of the LIV-1 subfamily of the ZIP transporter family. The encoded transmembrane protein functions as a zinc transporter. Mutations in this gene have been associated with the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. Alternate transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009007037).
BP6
Variant 11-47412369-C-G is Benign according to our data. Variant chr11-47412369-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 287155.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=7, Benign=1, Uncertain_significance=1}. Variant chr11-47412369-C-G is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC39A13NM_001128225.3 linkuse as main transcriptc.439C>G p.Gln147Glu missense_variant 4/10 ENST00000362021.9 NP_001121697.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC39A13ENST00000362021.9 linkuse as main transcriptc.439C>G p.Gln147Glu missense_variant 4/101 NM_001128225.3 ENSP00000354689 P4Q96H72-1

Frequencies

GnomAD3 genomes
AF:
0.00206
AC:
313
AN:
152242
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00379
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00298
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00170
AC:
425
AN:
250280
Hom.:
1
AF XY:
0.00179
AC XY:
243
AN XY:
135486
show subpopulations
Gnomad AFR exome
AF:
0.000433
Gnomad AMR exome
AF:
0.000811
Gnomad ASJ exome
AF:
0.00209
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00182
Gnomad NFE exome
AF:
0.00281
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00271
AC:
3959
AN:
1461738
Hom.:
8
Cov.:
32
AF XY:
0.00267
AC XY:
1943
AN XY:
727168
show subpopulations
Gnomad4 AFR exome
AF:
0.000418
Gnomad4 AMR exome
AF:
0.000850
Gnomad4 ASJ exome
AF:
0.00306
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.00122
Gnomad4 NFE exome
AF:
0.00324
Gnomad4 OTH exome
AF:
0.00255
GnomAD4 genome
AF:
0.00205
AC:
313
AN:
152360
Hom.:
3
Cov.:
33
AF XY:
0.00203
AC XY:
151
AN XY:
74510
show subpopulations
Gnomad4 AFR
AF:
0.000481
Gnomad4 AMR
AF:
0.00379
Gnomad4 ASJ
AF:
0.00317
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00160
Gnomad4 NFE
AF:
0.00298
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00270
Hom.:
1
Bravo
AF:
0.00193
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00337
AC:
29
ExAC
AF:
0.00152
AC:
184
EpiCase
AF:
0.00371
EpiControl
AF:
0.00231

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingGeneDxApr 07, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024SLC39A13: BP4, BS2 -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 26, 2017- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Ehlers-Danlos syndrome, spondylocheirodysplastic type Benign:2
Likely benign, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021SLC39A13 NM_152264.4 exon 4 p.Gln147Glu (c.439C>G): This variant has not been reported in the literature but is present in 0.3% (203/68032) of European alleles, including 3 homozygotes, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-47412369-C-G?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as likely benign (Variation ID: 287155). Evolutionary conservation for this variant is unclear. Computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 17, 2021The c.439C>G (p.Q147E) alteration is located in exon 4 (coding exon 3) of the SLC39A13 gene. This alteration results from a C to G substitution at nucleotide position 439, causing the glutamine (Q) at amino acid position 147 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 31, 2016- -
SLC39A13-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 23, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Ehlers-Danlos syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJun 13, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
24
DANN
Benign
0.92
DEOGEN2
Benign
0.011
T;.;T;T;.;.;T
Eigen
Benign
-0.16
Eigen_PC
Benign
0.047
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;D
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.0090
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.51
.;.;.;N;N;.;.
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.91
N;N;N;N;N;N;N
REVEL
Benign
0.12
Sift
Benign
1.0
T;T;T;T;T;T;T
Sift4G
Benign
0.54
T;T;T;T;T;T;T
Polyphen
0.084, 0.035, 0.93
.;.;.;B;B;.;P
Vest4
0.41
MVP
0.39
MPC
0.46
ClinPred
0.022
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.31
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148291843; hg19: chr11-47433920; COSMIC: COSV100712659; COSMIC: COSV100712659; API